Energy Transfer LP enters the week on the back foot, down 3.9% over five days to $19.60 — but the story here is less about selling pressure and more about a tide of analyst upgrades that arrived just before a sector-wide pullback.
The Street has been uniformly constructive since the Q1 earnings print in early May. Every firm that moved on ET raised its target. JP Morgan lifted to $24, Scotiabank moved to $24, Stifel pushed to $25, and a cluster of others — Barclays, TD Cowen, and Citi — all moved to $23 while keeping positive ratings. Then, today, Morgan Stanley raised its target to $23 from $21 while holding Equal-Weight — the one cautious voice in an otherwise bullish crowd. The mean price target now stands at $23.50, roughly 20% above Tuesday's close. That kind of gap is not typical for a stable midstream name, and it suggests the Street sees the recent pullback as an overreaction.
The pullback, however, is not unique to ET. The entire midstream complex sold off this week. Close peer fell 3.5%, dropped 2.7%, and shed 2.7%. held up best, losing less than 2%. The correlation is real — all four trade with better than 60% alignment to — so this week's move reads as a sector flush rather than stock-specific weakness.
Short positioning offers almost nothing of interest here. Short interest is under 1% of the free float — barely 31 million shares against a unit count deep in the billions. It has drifted fractionally higher over the month, up roughly 2%, but that is noise, not conviction. Borrow costs ticked up sharply on a week-over-week basis to 1.32%, but the absolute level remains trivial, and with availability sitting at effectively unlimited levels, the lending market presents zero friction for new shorts — nor any squeeze risk for existing ones. The ORTEX short score of 29 sits comfortably in non-threatening territory.
Options traders are equally sanguine. The put/call ratio is 0.17, almost exactly in line with its 20-day average of 0.16. There is no meaningful skew toward downside protection despite the week's price action. That combination — loose borrow, low short interest, and a PCR barely above its floor — describes a market where bears have little interest in ET as a short candidate.
Where the tension sits is in the fundamentals debate. Bulls point to gathering volumes up roughly 25% since 2022, a 5% projected revenue CAGR, and strategic assets like Sunoco underpinning the midstream franchise. The Piotroski F-Score has climbed from 5 to 7 since November, and the forward EPS momentum factor ranks at the 72nd percentile. Bears note that free cash flow swung to -$11 million in Q2 from +$32 million in Q1 as capex rose, the project backlog contracted 19% year-on-year to $240 million, and margin forecasts for FY26 have been revised down. Those are not catastrophic numbers for a partnership trading at 8.3x EV/EBITDA and 12.9x trailing earnings, but they explain why Morgan Stanley stays on the sideline even as it raises its target. The dividend score ranks at the 87th percentile — a reminder that for most holders, the distribution, not the capital gain, is the primary return driver.
The next scheduled earnings event is August 5. Between now and then, the key variable to watch is whether that free cash flow trough in Q2 proves transient or marks the start of a sustained capex-heavy period — that is the question on which the bull and bear cases diverge most sharply.
See the live data behind this article on ORTEX.
Open ET on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
